• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化病程中肝脏变化的病因学,考虑胆汁酸谱紊乱以及遗传和免疫因素。

Aetiopathogenesis of liver changes in the course of cystic fibrosis, considering disturbances of the bile acid profile as well as genetic and immunological factors.

作者信息

Więcek Sabina, Woś Halina, Grzybowska-Chlebowczyk Urszula

机构信息

Department of Paediatrics, Medical University of Silesia, Katowice, Poland.

出版信息

Prz Gastroenterol. 2013;8(5):290-4. doi: 10.5114/pg.2013.38730. Epub 2013 Oct 28.

DOI:10.5114/pg.2013.38730
PMID:24868271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4027825/
Abstract

Liver changes observed in the course of cystic fibrosis comprise a group of complex processes of fibrosis, inflammation, remodelling, apoptosis and cholestasis as a result of abnormal functioning of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, immunological reactions and response to oxidation stress. Liver lesions are only observed in 5-20% of patients with diagnosed cystic fibrosis; however, they increase mortality, reduce the lifespan and deteriorate the quality of life. Liver diseases are the most common extrapulmonary causes of death in patients with cystic fibrosis. The aim of the study was to analyse the hitherto performed studies on the aetiopathogenesis of liver changes in the course of cystic fibrosis considering disturbances of the bile acid profile as well as genetic and immunological factors.

摘要

在囊性纤维化病程中观察到的肝脏变化包括一组复杂的纤维化、炎症、重塑、细胞凋亡和胆汁淤积过程,这些过程是由囊性纤维化跨膜传导调节因子(CFTR)蛋白功能异常、免疫反应和对氧化应激的反应引起的。肝脏病变仅在5%-20%的已确诊囊性纤维化患者中观察到;然而,它们会增加死亡率、缩短寿命并降低生活质量。肝脏疾病是囊性纤维化患者最常见的肺外死亡原因。本研究的目的是分析迄今为止进行的关于囊性纤维化病程中肝脏变化的病因发病机制的研究,同时考虑胆汁酸谱的紊乱以及遗传和免疫因素。

相似文献

1
Aetiopathogenesis of liver changes in the course of cystic fibrosis, considering disturbances of the bile acid profile as well as genetic and immunological factors.囊性纤维化病程中肝脏变化的病因学,考虑胆汁酸谱紊乱以及遗传和免疫因素。
Prz Gastroenterol. 2013;8(5):290-4. doi: 10.5114/pg.2013.38730. Epub 2013 Oct 28.
2
Does the mutation of the SERPINA1 gene contribute to liver damage and cholestasis in patients with diagnosed cystic fibrosis? preliminary study.SERPINA1基因的突变是否会导致已确诊的囊性纤维化患者出现肝损伤和胆汁淤积?初步研究。
Dev Period Med. 2015 Jan-Mar;19(1):92-7.
3
Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.囊性纤维化跨膜传导调节因子在囊性纤维化患者肝脏组织中的表达。
Hepatology. 2000 Aug;32(2):334-40. doi: 10.1053/jhep.2000.9111.
4
Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies.囊性纤维化跨膜电导调节因子缺陷小鼠的胆囊排空和胆汁酸动态平衡缺陷。
Gastroenterology. 2012 Jun;142(7):1581-91.e6. doi: 10.1053/j.gastro.2012.02.033. Epub 2012 Feb 24.
5
The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis.囊性纤维化跨膜电导调节因子调节剂在囊性纤维化中的肺外作用。
Ann Am Thorac Soc. 2020 Feb;17(2):147-154. doi: 10.1513/AnnalsATS.201909-671CME.
6
Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.熊去氧胆酸可独立于囊性纤维化跨膜转导调节因子 (Cftr) 调节胆汁流量和胆汁盐池在小鼠中。
Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G1035-42. doi: 10.1152/ajpgi.00258.2011. Epub 2012 Feb 2.
7
[Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].[囊性纤维化患儿胃肠道症状的基因型与表型分析]
Pol Merkur Lekarski. 2005 Feb;18(104):205-9.
8
Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation.胆总管结扎后大鼠肝脏中囊性纤维化跨膜传导调节因子表达增加。
J Cell Physiol. 2005 Jun;203(3):599-603. doi: 10.1002/jcp.20259.
9
Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis.评估诊断为囊性纤维化患者的肝纤维化和炎症的选定参数。
Mediators Inflamm. 2020 Mar 25;2020:5696185. doi: 10.1155/2020/5696185. eCollection 2020.
10
Cholangiocyte biology and cystic fibrosis liver disease.胆管细胞生物学与囊性纤维化肝病
Semin Liver Dis. 2001 Nov;21(4):471-88. doi: 10.1055/s-2001-19030.

本文引用的文献

1
Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.囊性纤维化相关肝病中肝纤维化的转录基础。
J Pediatr Gastroenterol Nutr. 2012 Mar;54(3):328-35. doi: 10.1097/MPG.0b013e3182432034.
2
Cystic fibrosis-associated liver disease: when will the future be now?
J Pediatr Gastroenterol Nutr. 2012 Mar;54(3):312. doi: 10.1097/MPG.0b013e3182309fd0.
3
Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.小儿胆汁淤积性肝病:诊断、疾病进展评估及纤维化形成机制
World J Gastrointest Pathophysiol. 2010 Jun 15;1(2):69-84. doi: 10.4291/wjgp.v1.i2.69.
4
Cystic fibrosis-associated liver disease.囊性纤维化相关性肝病。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):585-92. doi: 10.1016/j.bpg.2010.08.003.
5
Outcome in cystic fibrosis liver disease.囊性纤维化肝病的转归。
Am J Gastroenterol. 2011 Jan;106(1):104-9. doi: 10.1038/ajg.2010.316. Epub 2010 Aug 24.
6
A marker associated with increased risk for severe liver disease in cystic fibrosis.与囊性纤维化严重肝脏疾病风险增加相关的标志物。
Clin Genet. 2010 May;77(5):434-5. doi: 10.1111/j.1399-0004.2009.01365_1.x.
7
Genetic modifiers of liver disease in cystic fibrosis.囊性纤维化肝病的基因修饰因子
JAMA. 2009 Sep 9;302(10):1076-83. doi: 10.1001/jama.2009.1295.
8
Screening for liver disease in cystic fibrosis: analysis of clinical and genetic risk factors for its development.囊性纤维化患者肝病的筛查:其发生的临床及遗传风险因素分析
Turk J Pediatr. 2008 Nov-Dec;50(6):526-32.
9
[Non invasive markers of non-alcoholic steatohepatitis].[非酒精性脂肪性肝炎的非侵入性标志物]
Pol Merkur Lekarski. 2008 Aug;25(146):166-70.
10
Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model.利用DeltaF508小鼠模型研究囊性纤维化肝病的病理生理基础。
Am J Physiol Gastrointest Liver Physiol. 2008 Jun;294(6):G1411-20. doi: 10.1152/ajpgi.00181.2007. Epub 2008 Apr 24.